Hypoglycemia

Manufacturer: Newton Laboratories, Inc.
Effective date: 2011-06-01
Label type: HUMAN PRESCRIPTION DRUG LABEL
Version: 1
Source: full-release
Hydrated at: 2026-06-01 02:05:10

Label at a glance#

ProductHypoglycemia

Active ingredientEpinephrine, Silver Nitrate, Arsenic Trioxide, Bryonia Alba Root, Cinchona Officinalis Bark, Graphite, Iodine, Iris Versicolor Root, Lachesis Muta Venom, Lycopodium Clavatum Spore, Sodium Chloride, Phosphorus, Phytolacca Americana Root, Sulfur, Thyroid, Unspecified

Label structure10 sections

Contacts and useful links#

PhoneLabel contact1.800.448.7256

Websitewww.newtonlabs.net

www.newtonlabs.net

Label contents#

Full prescribing information#

INDICATIONS & USAGE SECTION

Hypoglycemia Formulated for symptoms associated with blood sugar imbalance such as anxiety, trembling, palpitations, fatigue, irritability, headache and cravings.

DOSAGE & ADMINISTRATION SECTION

Directions: Ages 12 and up, take 6 pellets orally (ages 6 to 11, give 3 pellets) one to four times daily or as directed by a healthcare professional.

ACTIVE INGREDIENT SECTION

OTC - ACTIVE INGREDIENT SECTION

Adrenalinum 15x, Arg. nit. 15x, Arsenicum alb. 15x, Bryonia 15x, Cinchona 15x, Graphites 15x, Iodium 15x, Iris versicolor 15x, Lachesis 15x, Lycopodium 15x, Nat.mur. 15x, Phosphorus 15x, Phytolacca 15x, Sulphur 15x, Thyroidinum 15x.

PURPOSE SECTION

ABUSE SECTION

Formulated for symptoms associated with blood sugar imbalance such as anxiety, trembling, palpitations, fatigue, irritability, headache and cravings.

INACTIVE INGREDIENT SECTION

Inactive Ingredients: Gluten-free, non-GMO, beet-derived sucrose pellets.

QUESTIONS? SECTION

OTC - QUESTIONS SECTION

www.newtonlabs.net Newton Laboratories, Inc. FDA Est # 1051203 - Conyers, GA 30012
Questions? 1.800.448.7256

WARNINGS SECTION

Warning: Do not use if tamper - evident seal is broken or missing. Consult a licensed healthcare professional if pregnant, nursing or if symptoms worsen or persist for more than a few days. Keep out of reach of children.

PREGNANCY OR BREAST FEEDING SECTION

OTC - PREGNANCY OR BREAST FEEDING SECTION

Consult a licensed healthcare professional if pregnant, nursing or if symptoms worsen or persist for more than a few days.

KEEP OUT OF REACH OF CHILDREN SECTION

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

Keep out of reach of children.

PACKAGE LABEL

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
0b4ec9ca-d305-43fc-88dd-7a510313efe0	Product name	1	20260105
bb209f42-a85f-4fee-9d3d-c9dded168625	Product name	1	20251208
49628fc7-2031-4c28-bd31-0ef3aa8f44a3	Product name	3	20251118
cbf85893-59ef-423f-87d4-a573c000a8b9	Product name	8	20250731
b5b1095b-40cd-8a9e-b111-502545045b07	Product name	4	20250325
e190029e-423b-473c-8e04-2ada59b5b711	Product name	1	20250314
30b0ac6e-02aa-0e5c-0d8b-cffdf3a282b2	Product name	5	20250304
bed0530e-f939-4541-956b-6928a2f6404f	Product name	1	20241008
cefa60e2-a5b5-493e-9c54-24735b7dc509	Product name	6	20240814
63f39a63-5cd1-4016-bd86-2bbb0f6c3139	Product name	3	20240506
e5a77e9c-c528-733a-173d-914a234c024b	Product name	5	20240506
e0031c74-3853-42bc-8e10-86dbbe83992e	Product name	2	20231116
362d7abb-94e6-4c60-9a58-266894157713	Product name	1	20231023
f7046b89-2016-499a-adc6-78479172abc6	Product name	1	20230425
6bd95106-a412-1dad-b9cc-4cb74bfb27ce	Product name	2	20230315
5f30b278-5791-4113-8781-878a9221ef8a	Product name	2	20230125
f1e0dc7e-7d61-4625-b6d9-4894927679d7	Product name	2	20211025
e4870509-7e28-6f92-f0be-dd3dd889a9cf	Product name	5	20200810
2a70c781-a755-4d76-b20a-a958acfbdcdc	Product name	2	20190619
6e9d4a47-c464-b93e-aebc-ad7bffc9c4cd	Product name	2	20190619
444b3e50-f226-46ef-bfca-2e7035d140cd	Product name	1	20190611
816b97af-edc5-4060-aff1-b814bdbcad50	Product name	1	20190415
2686d634-e712-4007-8dbf-3d37c6c4d71f	Product name	1	20181121
304592ef-4a8a-4c22-8e8c-af73aa3d60e5	Product name	1	20180703
7cda52fc-125f-421c-8fea-bc1974370c49	Product name	2	20180703
ac0821a1-ce75-4ea7-880a-59eecaecdf22	Product name	1	20180703
db5dc4f9-b907-46f6-8fb7-babcf04bbe5c	Product name	1	20180619
fa8b5901-e681-426f-82fe-54f6d81ec698	Product name	4	20180619
bd49bb86-2d32-4a7a-a594-eeda2e29af42	Product name	1	20180118
c08ab52f-2fc8-4409-9d9f-ed8edc0bd070	Product name	1	20171221
cefa60e2-a5b5-493e-9c54-24735b7dc509	Product name	2	20171212
41e9d6cf-3ed7-4c44-a57e-0685058d0896	Product name	1	20170824
3becbe78-12d9-4ad2-9b4c-1e36f8d1303a	Product name	1	20170815
419aab54-5d5a-4146-9453-026d4a9991be	Product name	2	20170525
5e652c92-68fd-426b-b0e7-5fc64e0b9f99	Product name	1	20170309
d5e51f11-ad28-caa4-4b49-4143974782ad	Product name	1	20150831
290f523a-f9db-9774-b5a9-e1f908ac1782	Product name	1	20150828
ddc0c11a-bba8-408f-b3c7-c4828b4bcc8c	Product name	1	20150421
0ca1d589-929b-4b33-bc5b-1d84abdafa6a	Product name	1	20150324
fc363c46-397b-4476-ac0f-70e43e8e4592	Product name	1	20150324
89dac932-b90a-4410-9ab1-84c53e57de25	Product name	1	20150316
5668b646-cd56-c3c7-bdea-3f6b1a8840db	Product name	1	20140508
684ea482-2e8b-14af-5664-b98f1e402036	Product name	1	20140508
6cca4355-1206-91f7-02de-17eef38a8622	Product name	1	20140508
751c581a-bf64-2fd7-b3ec-ca02c83e4a00	Product name	1	20140508
810ab97e-f109-f41c-7c83-6a652a9cbf43	Product name	1	20140508
87711080-88eb-65c5-b2dd-bf99e700a372	Product name	1	20140508
8dbefedf-0a0d-a224-5a3c-66dc9e11c2dd	Product name	1	20140508
b060cc1a-fe47-856b-0b77-4448b5963de8	Product name	1	20140508
c6b65c52-69c7-df49-550a-a50c137f6218	Product name	1	20140508
ec2149b3-5c6d-5344-f757-c86411073075	Product name	1	20140508
ed912195-5da0-0f2f-6f4b-3ef17710cbe3	Product name	1	20140508

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDC	Effective	Action	Document	Indexing SPL	Related label
55714-4513-1	2020-01-31	C162847	48780-1	9d75b9cf-f737-f424-e053-dadaa90a57ce	Hypoglycemia
55714-4513-2	2020-01-31	C162847	48780-1	9d75b9cf-f737-f424-e053-dadaa90a57ce	Hypoglycemia

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	Strength	SPL version
55714-4513-1	Hypoglycemia	28.35 g in 1 BOTTLE, GLASS	PELLET	28.35		1
55714-4513-2	Hypoglycemia	56.7 g in 1 BOTTLE, GLASS	PELLET	56.7		1

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
55714-4513	HYPOGLYCEMIA (ADRENALINUM, ARG. NIT.,ARSENICUM ALB., BRYONIA, CINCHONA, GRAPHITES,IODIUM, IRIS VERSICOLOR, LACHESIS, LYCOPODIUM, NAT. MUR., PHOSPHORUS, PHYTOLACCA, SULPHUR,THYROIDINUM) PELLET [NEWTON LABORATORIES, INC.]	1	Legacy NDC, 2 package rows	20131107_f2e5d1f4-62dd-7298-481d-49fb6b4f285b.zip

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	SPL version
Arsenic Trioxide	ACTIVE INGREDIENT	S7V92P67HO	1
Bryonia Alba Root	ACTIVE INGREDIENT	T7J046YI2B	1
Cinchona Officinalis Bark	ACTIVE INGREDIENT	S003A158SB	1
Epinephrine	ACTIVE INGREDIENT	YKH834O4BH	1
Graphite	ACTIVE INGREDIENT	4QQN74LH4O	1
Iodine	ACTIVE INGREDIENT	9679TC07X4	1
Iris Versicolor Root	ACTIVE INGREDIENT	X43D4L3DQC	1
Lachesis Muta Venom	ACTIVE INGREDIENT	VSW71SS07I	1
Lycopodium Clavatum Spore	ACTIVE INGREDIENT	C88X29Y479	1
Phosphorus	ACTIVE INGREDIENT	27YLU75U4W	1
Phytolacca Americana Root	ACTIVE INGREDIENT	11E6VI8VEG	1
Silver Nitrate	ACTIVE INGREDIENT	95IT3W8JZE	1
Sodium Chloride	ACTIVE INGREDIENT	451W47IQ8X	1
Sulfur	ACTIVE INGREDIENT	70FD1KFU70	1
Thyroid, Unspecified	ACTIVE INGREDIENT	0B4FDL9I6P	1
Arsenic Cation (3+)	ACTIVE MOIETY	C96613F5AV	1
Bryonia Alba Root	ACTIVE MOIETY	T7J046YI2B	1
Chloride Ion	ACTIVE MOIETY	Q32ZN48698	1
Cinchona Officinalis Bark	ACTIVE MOIETY	S003A158SB	1
Epinephrine	ACTIVE MOIETY	YKH834O4BH	1
Graphite	ACTIVE MOIETY	4QQN74LH4O	1
Iodine	ACTIVE MOIETY	9679TC07X4	1
Iris Versicolor Root	ACTIVE MOIETY	X43D4L3DQC	1
Lachesis Muta Venom	ACTIVE MOIETY	VSW71SS07I	1
Lycopodium Clavatum Spore	ACTIVE MOIETY	C88X29Y479	1
Phosphorus	ACTIVE MOIETY	27YLU75U4W	1
Phytolacca Americana Root	ACTIVE MOIETY	11E6VI8VEG	1
Silver Cation	ACTIVE MOIETY	57N7B0K90A	1
Sulfur	ACTIVE MOIETY	70FD1KFU70	1
Thyroid, Unspecified	ACTIVE MOIETY	0B4FDL9I6P	1
Sucrose	INACTIVE INGREDIENT	C151H8M554	1

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 21 matching rows.

Hypoglycemia
Adrenalinum, Arg. nit.,Arsenicum alb., Bryonia, Cinchona, Graphites,Iodium, Iris versicolor, Lachesis, Lycopodium, Nat. mur., Phosphorus, Phytolacca, Sulphur,Thyroidinum
Epinephrine
Silver Nitrate
Silver Cation
Arsenic Trioxide
Arsenic Cation (3+)
Bryonia Alba Root
Cinchona Officinalis Bark
Graphite
Iodine
Iris Versicolor Root
Lachesis Muta Venom
Lycopodium Clavatum Spore
Sodium Chloride
Chloride Ion
Phosphorus
Phytolacca Americana Root
Sulfur
Thyroid, Unspecified
Sucrose

NDC Codes#

Product NDC, Package NDC table
Product NDC	Package NDC
55714-4513	55714-4513-1, 55714-4513-2

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 16 matching rows.

Name, UNII, Kind table
Name	UNII	Kind
Epinephrine	YKH834O4BH	ACTIB
Silver Nitrate	95IT3W8JZE	ACTIB
Arsenic Trioxide	S7V92P67HO	ACTIB
Bryonia Alba Root	T7J046YI2B	ACTIB
Cinchona Officinalis Bark	S003A158SB	ACTIB
Graphite	4QQN74LH4O	ACTIB
Iodine	9679TC07X4	ACTIB
Iris Versicolor Root	X43D4L3DQC	ACTIB
Lachesis Muta Venom	VSW71SS07I	ACTIB
Lycopodium Clavatum Spore	C88X29Y479	ACTIB
Sodium Chloride	451W47IQ8X	ACTIB
Phosphorus	27YLU75U4W	ACTIB
Phytolacca Americana Root	11E6VI8VEG	ACTIB
Sulfur	70FD1KFU70	ACTIB
Thyroid, Unspecified	0B4FDL9I6P	ACTIB
Sucrose	C151H8M554	IACT

Source Document#

Source XML

Inactive ingredient matches#

Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.

Inactive ingredient links page 1 of 1 · 48 matching rows.

DailyMed ingredient, IID ingredient, UNII table
DailyMed ingredient	IID ingredient	UNII	Dosage form / route	Potency	Maximum daily exposure	Match
Sucrose	SUCROSE	C151H8M554	WAFER / ORAL	155.2 mg		Exact identifier — unii candidate 48 equally ranked IID candidates
Sucrose	SUCROSE	C151H8M554	SUPPOSITORY / RECTAL	NA		Exact identifier — unii candidate 48 equally ranked IID candidates
Sucrose	SUCROSE	C151H8M554	INJECTION, SUSPENSION, EXTENDED RELEASE / SUBCUTANEOUS		1 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
Sucrose	SUCROSE	C151H8M554	INJECTION, POWDER, FOR SUSPENSION / INTRAVENOUS	900 mg		Exact identifier — unii candidate 48 equally ranked IID candidates
Sucrose	SUCROSE	C151H8M554	LOZENGE / BUCCAL	NA		Exact identifier — unii candidate 48 equally ranked IID candidates
Sucrose	SUCROSE	C151H8M554	SUSPENSION, EXTENDED RELEASE / ORAL		5400 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
Sucrose	SUCROSE	C151H8M554	GRANULE / ORAL	NA		Exact identifier — unii candidate 48 equally ranked IID candidates
Sucrose	SUCROSE	C151H8M554	INJECTION, SOLUTION / INTRAVENOUS	NA		Exact identifier — unii candidate 48 equally ranked IID candidates
Sucrose	SUCROSE	C151H8M554	TABLET, FILM COATED / ORAL		145 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
Sucrose	SUCROSE	C151H8M554	CAPSULE, COATED, EXTENDED RELEASE / ORAL		86 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
Sucrose	SUCROSE	C151H8M554	TROCHE / BUCCAL	NA		Exact identifier — unii candidate 48 equally ranked IID candidates
Sucrose	SUCROSE	C151H8M554	INJECTION / SUBCUTANEOUS	47.75 mg		Exact identifier — unii candidate 48 equally ranked IID candidates
Sucrose	SUCROSE	C151H8M554	TABLET, DELAYED RELEASE / ORAL	295.33 mg		Exact identifier — unii candidate 48 equally ranked IID candidates
Sucrose	SUCROSE	C151H8M554	GRANULE, FOR SUSPENSION, EXTENDED RELEASE / ORAL		18790 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
Sucrose	SUCROSE	C151H8M554	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / INTRAVENOUS		2000 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
Sucrose	SUCROSE	C151H8M554	INJECTION, EMULSION / INTRAVENOUS		970 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
Sucrose	SUCROSE	C151H8M554	ELIXIR / ORAL		18000 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
Sucrose	SUCROSE	C151H8M554	TABLET, CHEWABLE / ORAL		7258 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
Sucrose	SUCROSE	C151H8M554	CAPSULE, COATED PELLETS / ORAL	59.8 mg		Exact identifier — unii candidate 48 equally ranked IID candidates
Sucrose	SUCROSE	C151H8M554	POWDER, FOR SOLUTION / ORAL		38666 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
Sucrose	SUCROSE	C151H8M554	SUSPENSION / ORAL		48209 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
Sucrose	SUCROSE	C151H8M554	TABLET, COATED / ORAL	516.42 mg		Exact identifier — unii candidate 48 equally ranked IID candidates
Sucrose	SUCROSE	C151H8M554	SOLUTION / RECTAL	35.42 %w/v		Exact identifier — unii candidate 48 equally ranked IID candidates
Sucrose	SUCROSE	C151H8M554	SOLUTION / ORAL		70000 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
Sucrose	SUCROSE	C151H8M554	INJECTION / INTRAVENOUS		1950 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
Sucrose	SUCROSE	C151H8M554	INJECTION, SUSPENSION, LIPOSOMAL / INTRAVENOUS	9.4 %w/v		Exact identifier — unii candidate 48 equally ranked IID candidates
Sucrose	SUCROSE	C151H8M554	CAPSULE, EXTENDED RELEASE / ORAL		619 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
Sucrose	SUCROSE	C151H8M554	CAPSULE / ORAL		3568 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
Sucrose	SUCROSE	C151H8M554	GRANULE, FOR SOLUTION / ORAL		42596 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
Sucrose	SUCROSE	C151H8M554	SYRUP / ORAL		46400 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
Sucrose	SUCROSE	C151H8M554	TABLET, FILM COATED, EXTENDED RELEASE / ORAL	119.12 mg		Exact identifier — unii candidate 48 equally ranked IID candidates
Sucrose	SUCROSE	C151H8M554	POWDER, FOR SUSPENSION / ORAL		40017 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
Sucrose	SUCROSE	C151H8M554	CAPSULE, DELAYED RELEASE / ORAL		955 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
Sucrose	SUCROSE	C151H8M554	TROCHE / ORAL	NA		Exact identifier — unii candidate 48 equally ranked IID candidates
Sucrose	SUCROSE	C151H8M554	SUSPENSION/ DROPS / ORAL		3750 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
Sucrose	SUCROSE	C151H8M554	LOZENGE / TRANSMUCOSAL		1255 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
Sucrose	SUCROSE	C151H8M554	INJECTABLE, LIPOSOMAL / INTRAVENOUS		7560 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
Sucrose	SUCROSE	C151H8M554	PASTILLE / ORAL	426 mg		Exact identifier — unii candidate 48 equally ranked IID candidates
Sucrose	SUCROSE	C151H8M554	TABLET, EXTENDED RELEASE / ORAL	284.54 mg		Exact identifier — unii candidate 48 equally ranked IID candidates
Sucrose	SUCROSE	C151H8M554	TABLET / ORAL		4249 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
Sucrose	SUCROSE	C151H8M554	LIQUID / ORAL		37500 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
Sucrose	SUCROSE	C151H8M554	TABLET / SUBLINGUAL	109 mg		Exact identifier — unii candidate 48 equally ranked IID candidates
Sucrose	SUCROSE	C151H8M554	GRANULE, FOR SUSPENSION / ORAL		31885 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
Sucrose	SUCROSE	C151H8M554	DROPS / ORAL	NA		Exact identifier — unii candidate 48 equally ranked IID candidates
Sucrose	SUCROSE	C151H8M554	POWDER / ORAL		27768 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
Sucrose	SUCROSE	C151H8M554	TABLET / BUCCAL	109 mg		Exact identifier — unii candidate 48 equally ranked IID candidates
Sucrose	SUCROSE	C151H8M554	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / SUBCUTANEOUS		308 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
Sucrose	SUCROSE	C151H8M554	CONCENTRATE / ORAL		4800 mg	Exact identifier — unii candidate 48 equally ranked IID candidates

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
a171c4dd-5bf6-0fd7-6dab-47ccd0339610			f2e5d1f4-62dd-7298-481d-49fb6b4f285b	2011-06-01	Warnings	Exact identifier spl id: a171c4dd-5bf6-0fd7-6dab-47ccd0339610 spl set id: f2e5d1f4-62dd-7298-481d-49fb6b4f285b

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.